[1]崔康健,杜成友.肝動脈化療栓塞聯合射頻消融治療肝癌的研究進展[J].醫學信息,2018,(09):16-19,22.[doi:10.3969/j.issn.1006-1959.2018.09.005]
 CUI Kang-jian,DU Cheng-you.Research Progress of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for Liver Cancer[J].Medical Information,2018,(09):16-19,22.[doi:10.3969/j.issn.1006-1959.2018.09.005]
點擊復制

肝動脈化療栓塞聯合射頻消融治療肝癌的研究進展()
分享到:

醫學信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期數:
2018年09期
頁碼:
16-19,22
欄目:
終末期肝病的診斷與治療專題
出版日期:
2018-05-01

文章信息/Info

Title:
Research Progress of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for Liver Cancer
文章編號:
1006-1959(2018)09-0016-05
作者:
崔康健杜成友
重慶醫科大學附屬第一醫院肝膽外科,重慶 400016
Author(s):
CUI Kang-jianDU Cheng-you
Department of Hepatobiliary Surgery,First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China
關鍵詞:
肝癌非手術治療TACERFA
Keywords:
Key words:Liver cancerNon-surgical treatmentTACERFA
分類號:
R735.7
DOI:
10.3969/j.issn.1006-1959.2018.09.005
文獻標志碼:
A
摘要:
肝癌是我國常見的惡性腫瘤之一,死亡率居所有惡性腫瘤前列。肝動脈化療栓塞和射頻消融是兩種常用的肝癌非手術治療方法,隨著技術的不斷成熟,兩者聯合治療肝癌的優勢逐漸顯現,且應用越來越廣泛。本文就肝動脈化療栓塞聯合射頻消融治療肝癌的現狀進行綜述,以期為肝癌的治療提出新的思路與途徑。
Abstract:
Abstract:Liver cancer is one of the most common malignancies in China.Mortality ranks at the forefront of all malignancies.Hepatic arterial chemoembolization and radiofrequency ablation are two commonly used non-surgical treatment methods for liver cancer.As the technology continues to mature, the advantages of the two combined treatment of liver cancer gradually emerge,and more and more widely used.This article reviews the current status of hepatic arterial chemoembolization combined with radiofrequency ablation in the treatment of liver cancer,with a view to presenting new ideas and approaches for the treatment of liver cancer.

參考文獻/References:

[1]王征,樊嘉,周儉.ALPPS在肝臟外科的應用前景[J].肝膽外科雜志,2015,23(1):1-2.
[2]Sotiropoulos GC,Lang H,Frilling A,et al.Resectability of hepatocellular carcinoma:evaluation of 333 consecutive cases at a single hepatobiliary specialty center and systematic review of the literature[J].Hepato-gastroenterology,2006,53(53):322-329.
[3]Jiang FQ,Wei L,Chao Y.Curative effect of transcatheter arterial chemoembolization combined with radiofrequency ablation in treating hepatic cell carcinoma and the effect on serum markers [J].Cancer Biomarkers,2016,22(8):86-90.
[4]Siriapisith T,Siwasattayanon P,Tongdee T.Radiofrequency ablation alone versus radiofrequency ablation combined with chemoembolization in unresectable hepatocellular carcinoma[J].J Med Assoc Thai,2012,95(3):430.
[5]陳敏山,張耀軍.射頻消融在肝癌多學科綜合治療中的應用[C]//全國臨床腫瘤學大會暨2010年CSCO學術年會.2010.
[6]Feng K,Yan J,Li X,et al.A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma[J].Journal of Hepatology,2012,57(4):794-802.
[7]Pompili M,Saviano A,Matthaeis ND,et al.Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma≤3 cm.Results of a multicenter Italian survey[J].Journal of Hepatology,2013,59(1):89-97.
[8]Qi X,Tang Y,An D,et al.Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma:a meta-analysis of randomized controlled trials[J].Journal of Clinical Gastroenterology,2014,48(5):450.
[9]Choe WH,Kim YJ,Park HS,et al.Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma[J].World Journal of Gastroenterology,2014,20(35):12588.
[10]Roauaie S,Obeidat K,Sposito C,et al.Resection of Hepatocellular Cancer≤2 cm:Results from Two Western Centers[J].Hepatology,2013,57(4):1426-1435.
[11]Zhang N,Wang L,Chai ZT,et al.Incomplete Radiofrequency Ablation Enhances Invasiveness and Metastasis of Residual Cancer of Hepatocellular Carcinoma Cell HCCLM3 via Activating β-Catenin Signaling[J].Plos One,2014,9(12):e115949.
[12]王松,姜凱.肝癌射頻消融過程中熱效應的研究現狀[J].世界腫瘤研究,2016,6(4):31-35.
[13]Hyun D,Cho SK,Shin SW,et al.Treatment of Small Hepatocellular Carcinoma(≤2 cm)in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation[J].Cardiovascular&Interventional Radiology,2016,39(7):1015-1022.
[14]姬統理,杜錫林,李剛,等.肝動脈化療栓塞術加經皮肝穿刺射頻消融術治療原發性肝癌56例[J].現代腫瘤醫學,2004,12(6):540-541.
[15]Groeschl RT,Gamblin TC,Turaga KK.Ablation for Hepatocellular Carcinoma:Validating the 3 cm Breakpoint[J].Annals of Surgical Oncology,2013,20(11):3591-3595.
[16]Peng ZW,Zhang YJ,Chen MS,et al.Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma:A Prospective Randomized Trial[J].Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology,2013,31(4):426.
[17]Morimoto M,Numata K,Kondou M,et al.Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma:a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization[J].Cancer,2010,116(23):5452.
[18]中華人民共和國衛生和計劃生育委員會醫政醫管局.原發性肝癌診療規范(2017年版)[J].中華消化外科雜志,2017,16(7):705-720.
[19]王瑜.射頻消融后輔助肝動脈化療栓塞治療早期肝癌的前瞻性隨機對照研究[D].第三軍醫大學,2015.
[20]高松學,任偉新.肝動脈化療栓塞術聯合射頻消融治療肝癌的現狀[J].中國介入影像與治療學,2010,07(6):680-683.
[21]Liu H,Wang ZG,Fu SY,et al.Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria[J].British Journal of Surgery,2016,103(4):348-356.
[22]Takaki H,Yamakado K,Uraki J,et al.Radiofrequency Ablation Combined with Chemoembolization for the Treatment of Hepatocellular Carcinomas Larger than 5 cm [J].Journal of Vascular&Interventional Radiology,2009,20(2):217-224.
[23]Kuroda H,Kasai K,Kakisaka K,et al.Changes in liver function parameters after percutaneous radiofrequency ablation therapy in patients with hepatocellular carcinoma[J].Hepatology Research the Official Journal of the Japan Society of Hepatology,2010,40(5):550.
[24]Li JX,Wu H,Huang JW,et al.The influence on liver function after transcatheter arterial chemoembolization combined with percutaneous radiofrequency ablation in patients with hepatocellular carcinoma[J].J Formos Med Assoc,2012,111(9):510-515.
[25]Koda M,Ueki M,Maeda Y,et al.The influence on liver parenchymal function and complications of radiofrequency ablation or the combination with transcatheter arterial embolization for hepatocellular carcinoma[J].Hepatology Research the Official Journal of the Japan Society of Hepatology,2004,29(1):18-23.
[26]Kang SG,Yoon CJ,Jeong SH,et al.Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study[J].Journal of Vascular&Interventional Radiology Jvir,2009,20(12):1570-1577.
[27]Lencioni R,Llovet JM.Modified RECIST(mRECIST)assessment for hepatocellular carcinoma[J].Seminars in Liver Disease,2010,30(1):52.
[28]Shao GL,Zheng JP,Guo LW,et al.Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging:A prospective study[J].Medicine,2017,96(3):e5518.
[29]鄧士杰,高紀稱,王海屹.CT和MRI對射頻消融聯合肝動脈化療栓塞治療肝細胞肝癌療效評價的對比研究[J].山西醫藥雜志,2014,43(3):261-263.
[30]趙煒.GD-EOB-DTPA增強MRI對肝癌患者TACE-RFA術后療效評估的研究[D].南方醫科大學,2015.
[31]Kamiyama T,Yokoo H,Kakisaka T,et al.Multiplication of alpha-fetoprotein and protein induced by vitamin K absence-Ⅱ is a powerful predictor of prognosis and recurrence in hepatocellular carcinoma patients after a hepatectomy[J].Hepatology Research,2015,45(10):E21-E31.
[32]An SL,Xiao T,Wang LM,et al.Prognostic Significance of Preoperative Serum Alpha- fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors:a Single-center Experience from China[J].Asian Pacific Journal of Cancer Prevention Apjcp,2015,16(10):4421-4427.
[33]Meng W,Li X,Bai Z,et al.Silencing Alpha-Fetoprotein Inhibits VEGF and MMP-2/9 Production in Human Hepatocellular Carcinoma Cell[J].Plos One,2014,9(2):e90660.
[34]Yamada R,Hiramatsu N,Oze T,et al.Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection[J].Journal of Gastroenterology,2015,50(7):785.
[35]Z H,W Z.Novel insights into the molecular mechanisms of α-fetoprotein expression and malignant phenotypes of hepatocellular carcinoma[J].Cellular&Molecular Immunology,2012,9(1):7.
[36]Veltri A,Moretto P,Doriguzzi A,et al.Radiofrequency thermal ablation(RFA)after transarterial chemoembolization(TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma(HCC)[J].European Radiology,2006,16(3):661.
[37]Yan S,Xu D,Sum B.Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma:a meta-analysis[J].Digestive Diseases&Sciences,2012,57(11):3026-3031.
[38]Qi X,Zhao Y,Li H,et al.Management of hepatocellular carcinoma:an overview of major findings from meta-analyses[J].Oncotarget,2016,7(23):34703.
[39]Liu Z,Gao F,Yang G,et al.Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma:an up-to-date meta-analysis[J].Tumour Biology the Journal of the International Society for Oncodevelopmental Biology&Medicine,2014,35(8):1-7.
[40]黃文浩.肝動脈介入化療栓塞與射頻消融聯合治療肝癌的研究分析[J].中國衛生標準管理,2015,6(14):24-25.

相似文獻/References:

[1]韓林東,李 明.青少年特發性脊柱側彎非手術治療研究進展[J].醫學信息,2018,(08):28.[doi:10.3969/j.issn.1006-1959.2018.08.010]
 HAN Lin-dong,LI Ming.Progress in Non-operative Treatment of Adolescent Idiopathic Scoliosis[J].Medical Information,2018,(09):28.[doi:10.3969/j.issn.1006-1959.2018.08.010]
[2]修朋程,李 騰,李雅林,等.泰山山慈菇對小鼠肝癌的治療作用及相關免疫機制研究[J].醫學信息,2018,(09):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
 XIU Peng-cheng,LI Teng,LI Ya-lin,et al.Study on the Therapeutic Effect and Mechanism of Taishan Mountain Mushroom on Liver Cancer in Mice[J].Medical Information,2018,(09):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
[3]許 吉.基于知識圖譜和專利地圖的我國抗肝癌藥物研發態勢研究[J].醫學信息,2018,(21):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
 XU Ji.Research and Development Situation of Anti-liver Cancer Drugs in China Based on Knowledge Map and Patent Map[J].Medical Information,2018,(09):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
[4]蘭福全,李秀云,盧 斌.四種腫瘤標志物對肝癌診斷的臨床意義[J].醫學信息,2018,(21):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
 LAN Fu-quan,LI Xiu-yun,LU Bin.The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer[J].Medical Information,2018,(09):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
[5]趙瑤瑤,高 川,胡佳杰.循環miRNA監測肝細癌的研究[J].醫學信息,2019,(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
 ZHAO Yao-yao,GAO Chuan,HU Jia-jie.Research on the Study of Circulating miRNA for Monitoring Hepatocellular Carcinoma[J].Medical Information,2019,(09):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
[6]李 闖,葉勁松,劉 昕,等.ZBP-89與缺氧信號因子HIF-1α在肝癌細胞中的 相關性研究[J].醫學信息,2019,(15):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
 LI Chuang,YE Jin-song,LIU Xin,et al.Correlation between ZBP-89 and Hypoxia Signaling Factor HIF-1α in Hepatoma Cells[J].Medical Information,2019,(09):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
[7]孫 遜.性化護理對肝癌患者CT引導下射頻消融術后 負性情緒及生活質量的影響[J].醫學信息,2019,(17):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
 SUN Xun.Effect of Humanized Nursing on Negative Emotion and Quality of Life after CT-guided Radiofrequency Ablation in Patients with Liver Cancer[J].Medical Information,2019,(09):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
[8]徐 蓓,魏霞麗,常艷琴.肝癌患者術后自我飲食管理體驗的質性研究[J].醫學信息,2019,(20):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
 XU Bei,WEI Xia-li,CHANG Yan-qin.Qualitative Study of Postoperative Self-Catering Management Experience in Patients with Liver Cancer[J].Medical Information,2019,(09):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
[9]田 明,常偉平.UbcH10在肝癌中的表達及其與預后的關系[J].醫學信息,2019,(12):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
 IAN Ming,CHANG Wei-ping.Expression of UbcH10 in Hepatocellular Carcinoma and Its Relationship with Prognosis[J].Medical Information,2019,(09):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
[10]劉申穎,施彥卿,梅鵬飛,等.超聲引導下經皮無水乙醇注射聯合射頻消融治療中晚期肝癌的效果[J].醫學信息,2019,(22):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]
 LIU Shen-ying,SHI Yan-qing,MEI Peng-fei,et al.Ultrasound-guided Percutaneous Ethanol Injection Combined with Radiofrequency Ablation for Advanced Hepatocellular Carcinoma[J].Medical Information,2019,(09):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]

更新日期/Last Update: 2018-05-01
重庆时时开奖号码k线图